Back to search

Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in Patients With Acute VTE

Data up to Jan 2025

Published2011
Citations71
References24

Total Citations Per Year

Abstract

References (24)

Prevention of Venous Thromboembolism

2004 • 5,833 citations

Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin

1995 • 2,330 citations

Antithrombotic Therapy for Venous Thromboembolic Disease

2008 • 1,986 citations

Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings

2006 • 956 citations

Temporal Aspects of Heparin-Induced Thrombocytopenia

2001 • 946 citations

Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary Embolism

2003 • 885 citations

Treatment and Prevention of Heparin-Induced Thrombocytopenia

2008 • 820 citations

Heparin-Induced Thrombocytopenia

2006 • 721 citations

A diagnostic test for heparin-induced thrombocytopenia

1986 • 706 citations

Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous Thrombosis

2004 • 602 citations

Quantitative interpretation of optical density measurements using PF4‐dependent enzyme‐immunoassays

2008 • 347 citations

Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin

2005 • 275 citations

Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: How much class do we need?

2005 • 262 citations

Heparin‐induced thrombocytopenia: a prospective study on the incidence, platelet‐activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes

2007 • 232 citations

Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin

2004 • 213 citations

What is the potential for overdiagnosis of heparin‐induced thrombocytopenia?

2007 • 204 citations

Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin‐dependent antibodies

2005 • 184 citations

The epitope specificity of heparin‐induced thrombocytopenia

1996 • 156 citations

Fondaparinux for the treatment of patients with acute heparininduced thrombocytopenia

2007 • 144 citations

Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis

2001 • 132 citations

Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT)

2008 • 124 citations

Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux

2005 • 100 citations

Can heparin‐induced thrombocytopenia be associated with fondaparinux use? Reply to a rebuttal

2008 • 32 citations

Heparin–platelet factor 4 antibodies in patients presenting to the ED with thrombosis

2007 • 7 citations

Cited By (0)

Loading...
Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in… (2011) – CHEST Journal | Metascience Observatory Explorer